Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]

Ali A. Asadi-Pooya; Michael R. Sperling; Steve Chung; Pavel Klein; Anyzeila Diaz; Sami Elmoufti; Jimmy Schiemann; John Whitesides

首页> 外文期刊>Epilepsy research >Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]

【24h】

Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]

机译：误诊为先前抗癫痫药物暴露患者患者的疗效和耐受性和助长性和耐受性：HOC研究后的研究“癫痫 131（2017）70-75]

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Epilepsy research》 |2017年第2017期|共2页
作者
Ali A. Asadi-Pooya; Michael R. Sperling; Steve Chung; Pavel Klein; Anyzeila Diaz; Sami Elmoufti; Jimmy Schiemann; John Whitesides;
展开▼
作者单位

Jefferson Comprehensive Epilepsy Center Department of Neurology Thomas Jefferson University;

Jefferson Comprehensive Epilepsy Center Department of Neurology Thomas Jefferson University;

Banner University Medical Center;

Mid-Atlantic Epilepsy and Sleep Center;

UCB Pharma;

UCB Pharma;

UCB Pharma;

UCB Pharma;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献

1. Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75] [J] . Ali A. Asadi-Pooya, Michael R. Sperling, Steve Chung, Epilepsy research . 2017,第期

机译：误诊为先前抗癫痫药物暴露患者患者的疗效和耐受性和助长性和耐受性：HOC研究后的研究“癫痫 131（2017）70-75]
2. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis [J] . Glauser Tracy, Laurenza Antonio, Yang Haichen, Epilepsy research . 2016,第Null期

机译：基于基线时的抗癫痫药的数量和疗效的基线预测指标的辅助perampanel的疗效和耐受性：III期事后分析
3. APPLYING THE ACCEPTED TECHNIQUES OF INDIRECT TREATMENT COMPARISON TO MEET PAYER NEEDS FOR BRIVARACETAM VERSUS ADJUNCTIVE ANTIEPILEPTIC MEDICATIONS FOR THE TREATMENT OF FOCAL SEIZURES IN ADULT PATIENTS. DO THEY REFLECT THE NEED FOR INDIVIDUALISED PATIENT CARE IN HETEROGENEOUS POPULATIONS IN EPILEPSY? [J] . Charokopou M., Harvey R., Srivastava K., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：应用间接治疗比较的技术来满足支付需求的brariacetam对比辅助抗癫痫药物治疗成人患者的局部镇静。它们是否反映了癫痫患者中异质性人群个体化护理的需求？
4. Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study [O] . Marta Maschio, Andrea Maialetti, Cristina Mocellini, 2020

机译：Brivaracetam对脑肿瘤相关癫痫患者疗效和耐受性的影响：回顾性多中心研究
5. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis [O] . Glauser Tracy, Laurenza Antonio, Yang Haichen, 2016

机译：基于基线期抗癫痫药的数量和疗效的基线预测指标的辅助紫杉醇的疗效和耐受性：III期事后分析

Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]

著录项

相似文献

相关主题

期刊订阅